A Comparison of Percutaneous Ablation Therapy to Partial Nephrectomy for cT1a Renal Cancers: Results From the Canadian Kidney Cancer Information System. Reply.

The Journal of Urology(2023)

引用 0|浏览0
暂无评分
摘要
No AccessJournal of UrologyReply to Letters to the Editor11 Jan 2023A Comparison of Percutaneous Ablation Therapy to Partial Nephrectomy for cT1a Renal Cancers: Results From the Canadian Kidney Cancer Information System. Reply. Braden Millan and Anil Kapoor Braden MillanBraden Millan Division of Urology, McMaster Institute of Urology, McMaster University, Hamilton, Ontario, Canada More articles by this author and Anil KapoorAnil Kapoor * E-mail Address: [email protected] Division of Urology, McMaster Institute of Urology, McMaster University, Hamilton, Ontario, Canada More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003169AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookLinked InTwitterEmail "A Comparison of Percutaneous Ablation Therapy to Partial Nephrectomy for cT1a Renal Cancers: Results From the Canadian Kidney Cancer Information System. Reply.." The Journal of Urology, Publish Ahead of Print, pp. – References 1. . A comparison of percutaneous ablation therapy to partial nephrectomy for cT1a renal cancers: results from the Canadian Kidney Cancer Information System. J Urol.2022; 208(4):804-812. Link, Google Scholar 2. . Management of renal masses and localized renal cancer: systematic review and meta-analysis. J Urol.2016; 196(4):989-999. Link, Google Scholar 3. . Determining generalizability of the Canadian Kidney Cancer Information System (CKCis) to the entire Canadian kidney cancer population. Can Urol Assoc J.2020; 14(10):E499-E506. Google Scholar 4. . An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res.2011; 46(3):399-424. Google Scholar 5. . Propensity score analysis with missing data. Psychol Methods.2016; 21(3):427-445. Google Scholar 6. . Management and outcomes of tumor recurrence after focal ablation renal therapy. J Endourol.2010; 24(5):749-752. Google Scholar 7. . Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part I. J Urol.2021; 206(2):199-208. Link, Google Scholar Submitted January 4, 2023; accepted January 4, 2023; published 000. © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Braden Millan Division of Urology, McMaster Institute of Urology, McMaster University, Hamilton, Ontario, Canada More articles by this author Anil Kapoor Division of Urology, McMaster Institute of Urology, McMaster University, Hamilton, Ontario, Canada * E-mail Address: [email protected] More articles by this author Expand All Submitted January 4, 2023; accepted January 4, 2023; published 000. Advertisement PDF downloadLoading ...
更多
查看译文
关键词
ct1a renal cancers,partial nephrectomy,kidney cancers,percutaneous ablation therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要